Unjha Formulations Ltd

BSE : Unjha_Formul.12 Dec 2024

Pharmaceuticals

₹

-0.54 (-1.67%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Unjha Formulations Ltd

Unjha Formulations Ltd

Pharmaceuticals

BSE : Unjha_Formul.12 Dec 2024

₹

-0.54 (-1.67%)

OverviewFundamentals

Corporate action

Peer comparison

Cash flow

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
16-Oct-2024	BC	UNJHA FORMULATIONS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2024 inter alia to consider and approve Regulation 29(1)a of Listing Agreement	08-Nov-2024
08-Jul-2024	BC	AGM 16/08/2024 REGU 42(2) OF SEBI(LODR) ACT 2015 (As Per BSE Announcement dated on 08.07.2024) Regulation 30 of SEBI (LODR ) 2025 (As Per BSE Announcement Dated on 16.08.2024)	16-Aug-2024
16-Aug-2024	BC	Regulation 30 of SEBI (LODR ) 2025	16-Aug-2024
08-Jul-2024	BC	Annual General Meeting	10-Aug-2024
19-Jul-2024	BC	UNJHA FORMULATIONS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2024 inter alia to consider and approve Clause 29(1)(a) of Listing Agreement	01-Aug-2024

No Rights has been declared by Unjha_Formul.

Book Closure

Record Date	Split Date	Purpose
08-Nov-2024	-	UNJHA FORMULATIONS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2024 inter alia to consider and approve Regulation 29(1)a of Listing Agreement
16-Aug-2024	-	AGM 16/08/2024 REGU 42(2) OF SEBI(LODR) ACT 2015 (As Per BSE Announcement dated on 08.07.2024) Regulation 30 of SEBI (LODR ) 2025 (As Per BSE Announcement Dated on 16.08.2024)
16-Aug-2024	-	Regulation 30 of SEBI (LODR ) 2025
10-Aug-2024	01 Jan'1900	Annual General Meeting
01-Aug-2024	-	UNJHA FORMULATIONS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2024 inter alia to consider and approve Clause 29(1)(a) of Listing Agreement

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Unjha Formulations Ltd ₹31.71(-0.54/-1.67%)	31.71	-0.54	14.45	104.11	18.02	4.35
Ambalal Sarabhai Enterprises Ltd ₹65.57(+0.41/0.63%)	65.57	+0.41	499.34	59.86	56.66	11.08
Astrazeneca Pharma India Ltd ₹6,636.00(+40.95/0.62%)	6,636.00	+40.95	16,487.63	40.29	128.08	24.27
Amrutanjan Health Care Ltd ₹751.60(+2.05/0.27%)	751.60	+2.05	2,167.00	26.21	45.59	7.28
Abbott India Ltd ₹28,722.10(-143.05/-0.50%)	28,722.10	-143.05	61,338.44	25.24	47.75	17.42
Bliss GVS Pharma Ltd ₹173.80(+22.00/14.49%)	173.80	+22.00	1,598.94	15.22	19.79	1.56

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Cash and Cash Equivalents at Beginning of the year	0.01	0.43	0.17	0.94	0.65
Net Cash from Operating Activities	1.03	-0.26	0.28	-0.70	0.39
Net Cash Used In Investing Activities	-0.11	-0.10	-0.02	-0.06	-0.10
Net Cash Used In Financing Activities	-0.05	-0.06	0.00	0.00	0.00
Net Inc./Dec In Cash And Cash Equivalents	0.86	-0.42	0.25	-0.77	0.29
Cash And Cash Equivalents At End Of The Year	0.87	0.01	0.43	0.17	0.94

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

36.92%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

63.08%

**Promoter pledged shareholding 36.92%

About Unjha Formulations Ltd

Unjha Formulations Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 14.45 crores. It has reported a sales of Rs. 3.78 crores and a net profit of Rs. -0.11 crores for the quarter ended December 2018. The company management includes Jashodaben S Patel, Krutiben M Patel,Hasmukh C Chavda,Jashodaben S Patel,Jitendrakumar Parshottamdas Limbachiya,Jigar Ray,Mustufa Najmuddin,Esham. Patel (Unjha Formulations Ltd) among others.

Chairman

Jashodaben S Patel

Registered office

Khali Char Rasta,State Highway Ta Sidhpur,Patan,Gujarat,384151

FAX :91-2767-282396

Background

Incorporation Year1994

Face Value₹10

Market Lot1